Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
29 Aug 2026, 1:00 pm6d left
Inj Nivolumab 240mg
Inj Bevacizumab 800 mg
Tab Darolutamide 600mg
inj Cycloposphamide 500mg plus 250ml NS plus Darzalex Faxpro 1800mg
Inj Avelumab 800 Mg
9721365
GEM/2026/B/7887378
Two Packet Bid
Inj Nivolumab 240mg,Inj Bevacizumab 800 mg,Tab Darolutamide 600mg,inj Cycloposphamide 500mg plus 25
Gaya, Bihar
Item wise evaluation
BOQ
4 documents required · 4 mandatory
Commanding Officer, Military Hospital Gaya, Department of Military Affairs, Indian Army, Ministry of Defence, (Commanding Officer, Mh Gaya)
Exempted
Yes
19 Aug 2026
19 Aug 2026
29 Aug 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Inj Nivolumab 240mg | Inj Nivolumab 240mg | 2 | Vial | GAYA | 20 |
| 1 | Inj Bevacizumab 800 mg | Inj Bevacizumab 800 mg | 18 | Vial | GAYA | 20 |
| 1 | Tab Darolutamide 600mg | Tab Darolutamide 600mg | 300 | No | GAYA | 20 |
| 1 | inj Cycloposphamide 500mg plus 250ml NS plus Darzalex Faxpro 1800mg | inj Cycloposphamide 500mg + 250ml NS+Darzalex Faxpro 1800mg | 3 | Vial | GAYA | 20 |
| 1 | Inj Avelumab 800 Mg | Inj Avelumab 800 Mg | 14 | Vial | GAYA | 20 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9721365.pdf
GEM_BID • 0.12 MB
technical_sp_rac_2026-08-06-20-38-35_d2bfeaac337308a3149a2647683e1cab.pdf
BOQ • 1.51 MB
boq_item_sample_file_2026-08-06-20-38-35_86155911314bcf6921a2f87ce50ac351.csv
BOQ • 0.00 MB
TC_da4c984d-b968-4036-a0fb1786029381996_anurangroy.pdf
GEM_OTHER • 2.60 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].